I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Recent developments in receptor tyrosine kinase inhibitors:..:
Kumar, Rahul
;
Goel, Harsh
;
Solanki, Raghu
...
Medicine in Drug Discovery. 23 (2024) - p. 100195 , 2024
Link:
https://doi.org/10.1016/j.medidd.2024.100195
RT Journal T1
Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.medidd.2024.100195&Exemplar=1&LAN=DE A1 Kumar, Rahul A1 Goel, Harsh A1 Solanki, Raghu A1 Rawat, Laxminarayan A1 Tabasum, Saba A1 Tanwar, Pranay A1 Pal, Soumitro A1 Sabarwal, Akash PB Elsevier BV YR 2024 SN 2590-0986 JF Medicine in Drug Discovery VO 23 SP 100195 LK http://dx.doi.org/https://doi.org/10.1016/j.medidd.2024.100195 DO https://doi.org/10.1016/j.medidd.2024.100195 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)